课题基金 / 基金详情

Cell and Virus CORE

Cell and Virus CORE
细胞和病毒核心
批准号：
7600770
负责人：
David J Rawlings
金额：
$17.5万
依托单位：
SEATTLE CHILDREN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-09-30 至 2012-06-30
来源：
https://reporter.nih.gov/project-details/7600770
关键词：
AffinityAnimalsAttentionAvidityB-LymphocytesBindingBiological AssayCalibrationCanis familiarisCapitalCell LineCell SeparationCellsCompatibleConfusionCore FacilityCultured CellsDNADevelopmentElementsEngineeringEngraftmentEnsureEquipmentFacility Construction Funding CategoryFamiliarityFiltrationFlow CytometryFrequenciesGene TargetingGene TransferGenerationsGenesGoalsHeadHematopoieticHematopoietic stem cellsHomingHourHumanHuman ResourcesImmuneImmune systemImmunoglobulin Somatic HypermutationImmunologyIndividualIntegraseJointsLaboratoriesLentivirus VectorLibrariesMGMT geneMagnetismMaintenanceMethodsModificationMusNaturePediatric HospitalsPopulationPreparationProductionPropertyProteinsRateReporterReportingResearchResearch PersonnelResourcesRiskScreening procedureSideSiteSorting - Cell MovementStandards of Weights and MeasuresStem cellsSubfamily lentivirinaeSucroseSupporting CellSurfaceSystemTechnologyTimeTransplantationUltracentrifugationVariantVertebral columnViralVirusWeekWorkZinc Fingersabstractingbasecell typecostdesignendonucleaseenhancing factorexperiencegene repairimmune functionin vivoinstrumentinstrumentationmagnetic cell separationnovelnucleaseparticlepromoterreconstitutionrepairedresearch studyvectorvirus core

项目摘要

项目成果

David J Rawlings的其他基金

相似基金

相关文献

中文摘要
翻译
细胞和病毒核心旨在支持NGEC的两项主要活动：细胞分离和 自灭活非整合慢病毒载体及病毒的分析、构建和生产 股票。AutoMAC、流式细胞仪和分选将在LHE设计的组件2-5中大量使用， 以及用于荧光报告分析和体内基因免疫功能分析的成分6-8 目标定位和修复实验。零载体将用于交付LHE‘s和供体模板 从组件1中选择的实验，以及在组件6-8中提出的几乎所有实验。
英文摘要
The Cell and Virus Core is designed to support two major activities of the NGEC: cell separations and analysis, and construction and production of self inactivating non-integrating lentiviral (NIL) vectors and viral stocks. AutoMACs and flow cytometry and sorting will be heavily utilized in Components 2-5 for LHE design, and in Components 6-8 for analysis of fluorescent reporter assays and immune function in in vivo gene targeting and repair experiments. NIL vectors will be used for delivery of LHE's and donor templates in selected experiments from Component 1, and in virtually all experiments proposed in Components 6-8.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An integrated strategy to define the functional and synergistic impact of T1D causal variants
  • 批准号：
    9227381
  • 项目类别：
  • 资助金额：
    $441.14万
  • 财政年份：
    2016
  • 负责人：
    David J Rawlings
  • 依托单位：
    SEATTLE CHILDREN'S HOSPITAL
Lentiviral Gene Therapy of X-Linked Agammaglobulinemia
  • 批准号：
    8825754
  • 项目类别：
  • 资助金额：
    $8.78万
  • 财政年份：
    2014
  • 负责人：
    David J Rawlings
  • 依托单位：
    SEATTLE CHILDREN'S HOSPITAL
Administrative Core
  • 批准号：
    8278876
  • 项目类别：
  • 资助金额：
    $6.3万
  • 财政年份：
    2012
  • 负责人：
    David J Rawlings
  • 依托单位：
    SEATTLE CHILDREN'S HOSPITAL
Pre-clinical Modeling of Foamy Viral gene Therapy for Murine and Human SCID-X1
  • 批准号：
    8278864
  • 项目类别：
  • 资助金额：
    $25.01万
  • 财政年份：
    2012
  • 负责人：
    David J Rawlings
  • 依托单位：
    SEATTLE CHILDREN'S HOSPITAL
海外基金